WEDNESDAY, Feb. 18, 2026 -- The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1...
Vous n'êtes pas connecté
Maroc - Times of India - Life & Style - 13/12/2024 17:13
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
WEDNESDAY, Feb. 18, 2026 -- The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1...
WEDNESDAY, Feb. 18, 2026 -- The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1...
Ozempic and other GLP-1 agonist drugs have become an enormously popular way to lose weight. And with generic, much cheaper versions of the medications...
NVO shares swing sharply after fears over cheap compounded GLP-1 pills, before FDA action and a Hims retreat spark a sharp rebound.
When the fountain of youth’s under construction, you may want to dip into peptides instead. Chances are you’ve already heard of a number of...
When the fountain of youth’s under construction, you may want to dip into peptides instead. Chances are you’ve already heard of a number of...
A tentative agreement was reached between the New York State Nurses Association and the Mount Sinai Health System and Montefiore Medical Center.
The largest nurses' strike in NYC history moved two steps closer to ending Monday: Tentative agreements are now in place at Mount Sinai and...
Scientists have discovered why ovarian cancer spreads...
Hims had planned to sell the drug at a sharply discounted price of $49 for the first month, which is almost $100 less than Novo's approved Wegovy...